Novartis Ag (NVS) Cash from Operations (2009 - 2026)
Novartis Ag's Cash from Operations came in at $5.88 billion for Q2 2026, down 11.7% from $6.66 billion a year earlier but up 60.0% from the prior quarter.
Novartis Ag (NVS) Cash from Operations (2009 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Novartis Ag reported Cash from Operations of $18.39 billion, down 11.5% year-over-year; for FY2025, it was $19.14 billion, up 8.7% from FY2024.
- Cash from Operations has increased in each of the last four years, with a five-year compound annual growth rate of 7.0% (FY2020 to FY2025).
- Going back by year, Cash from Operations was $17.62 billion in FY2024 (+9.3%), $16.12 billion in FY2023 (+10.4%), $14.61 billion in FY2022 (+9.3%) and $13.37 billion in FY2021 (-2.1%).
- The five-year range for quarterly Cash from Operations is $1.65 billion (Q1 2022) to $6.66 billion (Q2 2025).
- Year-over-year, Cash from Operations increased in six of the last eight quarters, with growth averaging 11.4%.
- The fastest year-over-year change in Cash from Operations over five years came in Q1 2023 (growth of 188.2%), and the weakest in Q1 2024 (a decline of 52.3%).
- Business Quant data shows NVS's Cash from Operations at $3.68 billion (Q1 2026), $2.26 billion (Q4 2025) and $6.57 billion (Q3 2025) in the three quarters before Q2 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 10.69 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 8.62 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 3.44 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 5.37 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 5.88 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 4.58 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 4.00 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 3.57 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 835.00 Mn |
| 10 | Vertex Pharmaceuticals | 127.87 Bn | 99.88 Bn | 2.84 Bn | 1.13 Bn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 5.88 Bn |
| Mar 31, 2026 | 3.68 Bn |
| Dec 31, 2025 | 2.26 Bn |
| Sep 30, 2025 | 6.57 Bn |
| Jun 30, 2025 | 6.66 Bn |
| Mar 31, 2025 | 3.65 Bn |
| Dec 31, 2024 | 4.19 Bn |
| Sep 30, 2024 | 6.29 Bn |
| Jun 30, 2024 | 4.88 Bn |
| Mar 31, 2024 | 2.27 Bn |
| Dec 31, 2023 | 3.28 Bn |
| Sep 30, 2023 | 5.30 Bn |
| Jun 30, 2023 | 3.52 Bn |
| Mar 31, 2023 | 4.75 Bn |
| Dec 31, 2022 | 3.77 Bn |
| Sep 30, 2022 | 4.28 Bn |
| Jun 30, 2022 | 3.76 Bn |
| Mar 31, 2022 | 1.65 Bn |
| Dec 31, 2021 | 3.88 Bn |
| Sep 30, 2021 | 4.93 Bn |
Novartis Ag Cash from Operations API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-from-operations&ticker=NVS&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-from-operations", "ticker": "NVS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=cash-from-operations&ticker=NVS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();